Who owns Milprazon?
Milprazon is owned by Krka (Slovenia, LJSE: KRKG).[1]
This ownership is reported in official statements but has not yet been matched to a regulatory filing.
Evidence: Krka 2025 Annual Report, Krka, d. d., Novo mesto, 23 March 2026. Last checked .
Key facts
- Current owner
- Krka, tovarna zdravil, d. d., Novo mesto reported
- Owner HQ
- 🇸🇮 Slovenia, Novo mesto
- Origin
- 🇸🇮 Slovenia
- Founded
- 2015
- Category
- Pet & animal care › Pet supplies & services › Veterinary services
- Parent ticker
- LJSE: KRKG WSE: KRK
- Last verified
- · 1 sources
About Milprazon
Milprazon combines milbemycin with praziquantel as a broad-spectrum antiparasitic for cats and dogs, and was Krka's best-selling animal health product in 2025 as in the year before. More than sixty per cent of its sales are of Milprazon Chewable, a liver-flavoured tablet carrying the Easy To Give certification awarded by the cat charity iCatCare. Krka launched it in the United Arab Emirates and Jordan in 2025.
Ownership timeline of Milprazon
Where Milprazon sits in Krka
Controlling ownership as of . Brands grouped under the entity that owns them; large groups are collapsed.
Open the full Krka ownership tree →
See the full Krka brand portfolio (18) →
Other brands owned by Krka
Krka controls 18 brands on Brandtree, 4 of them in pet & animal care.
Also in pet & animal care
Other brands in veterinary services, and who owns them
The 46 brands in veterinary services on Brandtree belong to 8 owners. The largest is Zoetis, with 17; Krka has 4.
| Brand | Owner | Owner based in |
|---|---|---|
| Apoquel | Zoetis | 🇺🇸 United States |
| Advantage | Elanco | 🇺🇸 United States |
| Caniviton | Vetoquinol | 🇫🇷 France |
| Banfield Pet Hospital | Mars | 🇺🇸 United States |
| Chewy Vet Care | Chewy | 🇺🇸 United States |
| Vets for Pets | Pets at Home | 🇬🇧 United Kingdom |
| Rejensa | Phibro | 🇺🇸 United States |
| Cerenia | Zoetis | 🇺🇸 United States |
About the owner: Krka
Krka is a publicly listed company headquartered in Novo mesto, Slovenia, founded in 1954. Brandtree records 18 brands under its control, and it is listed as LJSE: KRKG and WSE: KRK.
Krka is a Slovenian generic pharmaceutical maker established in Novo mesto in 1954, listed in Ljubljana since 1997 and dual-listed in Warsaw since 2012. Group revenue was €2,041.0 million in 2025 and net profit €403.7 million. Prescription medicines are the bulk of it, but Krka also sells non-prescription products and animal health products, and its Slovenian subsidiary Terme Krka runs four health resorts. At home it is the largest supplier of medicines by value and says one in every five medicines sold in Slovenia is its own.
🇸🇮 Milprazon and other Slovenian brands
Brandtree records a controlling owner for 31 brands that began in Slovenia. 10 of them (32%) are now controlled by a company headquartered in another country; Milprazon is not one of them.
Frequently asked questions
Who is the parent company of Milprazon?
The parent company of Milprazon is Krka, a publicly listed company headquartered in Slovenia.
Is Milprazon Slovenian?
Yes. Milprazon originated in Slovenia in 2015 and its owner, Krka, is also headquartered in Slovenia.
Is Milprazon still owned by Krka?
Yes. As of 10 October 2026, Milprazon is still owned by Krka. The ownership record was last checked against primary sources on that date.
Sources (1) & corrections
Last verified . Every ownership fact above is backed by one of these primary documents. Numbers in brackets in the text refer to this list.
- [1] Krka 2025 Annual Report — Krka, d. d., Novo mesto, Annual report, published 23 March 2026; retrieved 16 September 2026.
Report a correction Opens a pre-filled GitHub issue. See our corrections policy.